Physician
Starakiewicz, Maria
Starakiewicz, Maria was paid $749K by Medicaid between Jan 2018 and Nov 2024, across 30 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 38% of everything it billed.
33Billing provider infoSTARAKIEWICZ, MARIA
CUMBERLAND, RI 02864
CUMBERLAND, RI 02864
33aNPI1003853037assigned 05/31/2006
33bProvider typePediatrics Physician
28Total paid$749K
24GClaims14,431
24DCodes billed30
24AFirst – last monthJan 2018 – Nov 2024
Compared with peers
Next to other Pediatrics Physician providers in Rhode Island
Rank by total paid#30 of 265
Median peer was paid$133K
This provider vs. median5.6×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,815 | $64K | |
| 2019 | 407 | $16K | |
| 2020 | 1,798 | $67K | |
| 2021 | 2,425 | $100K | |
| 2022 | 2,851 | $163K | |
| 2023 | 3,157 | $208K | |
| 2024incomplete | 1,978 | $131K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38% | 4,025 | 3,519 | $282K |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 28% | 2,042 | 1,874 | $208K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 7.3% | 455 | 435 | $55K |
| 92587 | 4.8% | 658 | 648 | $36K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 4.4% | 1,976 | 1,906 | $33K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 3.5% | 286 | 283 | $26K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.7% | 208 | 204 | $20K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 2.3% | 1,448 | 1,389 | $17K |
| 97802 | 1.8% | 683 | 668 | $13K | |
| 90461 | 1.5% | 451 | 434 | $11K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 1.3% | 249 | 241 | $10K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 1.2% | 12 | 12 | $9K |
18 more codes
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 27 | $5K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 39 | $5K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 365 | $4K |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 149 | $3K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 30 | $2K |
| 99177 | <1% | 444 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 169 | $2K |
| 99188 | <1% | 90 | $1K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 74 | $881.47 |
| 96127 | <1% | 216 | $696.91 | |
| 99401 | <1% | 24 | $682.92 | |
| 99050 | <1% | 16 | $549.93 | |
| 90480 | <1% | 18 | $434.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 29 | $351.26 |
| 81002 | <1% | 100 | $218.20 | |
| 90686 | <1% | 107 | $53.00 | |
| 96161 | <1% | 12 | $47.50 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 29 | $1.11 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.